Advertisement
Home Authors Posts by HealthDay.com

HealthDay.com

34810 POSTS 0 COMMENTS
Midlife type 2 diabetes is associated with an increased risk for cerebral infarction and cerebral artery occlusion in late life

Midlife Type 2 Diabetes May Up Later Risk for Cerebral Infarction

Genetic, early-life familial environmental factors seem not to contribute to link
Recipient overall survival is similar for overdose-death donor (ODD) and non-ODD cardiac transplants

Overdose-Death Donor Hearts Suitable for Transplant

Proportion of cardiac transplantations from ODDs increased; no difference seen in terms of overall survival
Children of men with testicular germ-cell cancer have a modestly increased risk for congenital malformation

Testicular Cancer Treatment Does Not Up Risk for Offspring Birth Defects

No increased risk seen at posttreatment in children of fathers with testicular germ-cell cancer
Fewer U.S. Army personnel have ideal cardiovascular health compared with their peers in the civilian population

Cardiovascular Health Poorer in Army Personnel Than Civilians

Prevalence of ideal blood pressure lower in U.S. Army personnel versus NHANES respondents
For middle-aged adults

Increase in CV Mortality Smaller With Medicaid Expansion

Counties in states that expanded Medicaid had significantly smaller increase in cardiovascular mortality
There seems to be no evidence of a legacy effect or mortality benefit for intensive glucose control among military veterans with type 2 diabetes

No Evidence of Legacy Effect Seen for Intensive Glucose Lowering

Findings based on 15-year follow-up study conducted among veterans with type 2 diabetes
Fragmentation profiles of cell-free DNA can differentiate between patients with cancer and healthy controls

Fragmentation Profiles of Cell-Free DNA Can Detect Cancer

Combined with mutation-based cell-free DNA analyses, 91 percent of cancer patients identified
The electronic-AsthmaTracker app aids self-monitoring and improves asthma outcomes among pediatric patients and their parents

App Helps Pediatric Asthma Patients, Parents Self-Monitor

With one year of use, improvements seen in asthma outcomes
While oncology providers are aware of the link between obesity and cancer

Few Oncologists Refer Patients to Weight Management Programs

Providers need more support to refer patients to weight management, physical activity programs
The U.S. Food and Drug Administration granted Emgality (galcanezumab-gnlm) solution the first approval for treating episodic cluster headache

Emgality Receives First FDA Approval for Treating Cluster Headache

Patients treated with Emgality had 8.7 fewer cluster headache attacks at 3.0 weeks versus 5.2 with placebo